CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
Abstract Introduction Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension. Methods Multicenter randomized clinical trial. Eligible patients had 2 systolic blood pres...
Saved in:
Main Authors: | W. Frank Peacock, Joseph Varón, Brigitte M. Baumann, Pierre Borczuk, Chad Cannon, Abhinav Chandra, David Cline, Deborah B. Diercks, Brian Hiestand, Amy P. Hsu, P. Jois-Bilowich, Brian Kaminski, Philip Levy, Richard M. Nowak, Jon W. Schrock |
---|---|
Format: | Artigo |
Language: | English |
Published: |
2011
|
Online Access: | https://doi.org/10.1186/cc10289 https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc10289 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department
by: Peacock, W Frank, et al.
Published: (2011) -
Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: a subgroup analysis of the CLUE trial
by: Cannon, Chad M, et al.
Published: (2013) -
Intracranial effects of nicardipine
by: Gaab, M. R., et al.
Published: (1985) -
Erythromelalgia induced by nicardipine.
by: Drenth, J. P.
Published: (1989) -
Erythromelalgia induced by nicardipine.
by: Levesque, H., et al.
Published: (1989)